OTCMKTS:SZLSF

Stagezero Life Sciences (SZLSF) Stock Price, News & Analysis

Stagezero Life Sciences logo
$0.01 0.00 (0.00%)
As of 11/13/2026 04:49 PM Eastern

About Stagezero Life Sciences Stock (OTCMKTS:SZLSF)

Advanced

Key Stats

Today's Range
$0.01
▼
$0.01
50-Day Range
N/A
52-Week Range
$0.0010
▼
$0.01
Volume
935 shs
Average Volume
25 shs
Market Capitalization
$1.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

StageZero Life Sciences Ltd. is a healthcare company focused on molecular diagnostics and precision medicine. The company develops blood-based tests designed to support the detection and management of cancer and other diseases, with an emphasis on identifying molecular signals that may be difficult to detect through conventional methods.

StageZero’s principal diagnostic product is Aristotle, a multi-cancer screening test that analyzes gene-expression patterns in a blood sample. The company has also worked to combine diagnostic testing with telehealth and clinical services, allowing patients to access testing, physician consultations and follow-up care through an integrated healthcare model.

The company is based in Canada and has pursued commercial and clinical opportunities in North America. StageZero’s activities have included laboratory development, clinical validation and efforts to expand access to its molecular diagnostic and telehealth offerings. Specific information about its current leadership and geographic operations is limited.

AI Generated. May Contain Errors.

Receive SZLSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stagezero Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SZLSF Stock News Headlines

StageZero Life Sciences Ltd. (SZLSF)
Your Copy is on Hold (Claim it now)
James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on Elon Musk's next big industry play. He estimates it could create 1.8 million new millionaires in the coming years, and shows how to position in the company at its center for under $60. Inside: the company's name and ticker, plus an FCC filing James believes reveals Elon's plan to take over a $25 trillion industry. He also flags December 8 as a key date.tc pixel
Dually-Listed Healthcare Stock Rallies On Q1 Results
See More Headlines

SZLSF Stock Analysis - Frequently Asked Questions

Stagezero Life Sciences' stock was trading at $0.0005 at the beginning of the year. Since then, SZLSF stock has increased by 1,900.0% and is now trading at $0.01.

Shares of SZLSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
11/16/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:SZLSF
CIK
1454263
Employees
80
Year Founded
1998

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
123,550,000
Free Float
120,415,000
Market Cap
$1.24 million
Optionable
Not Optionable
Beta
-4.01

Social Links

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (OTCMKTS:SZLSF) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners